Sularte, Larry Kim, Jr. .
HRN: 28-32-30 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/23/2025
12/29/2025
IV
380mg
Q6
PCAP
Checking Final Appropriateness
12/24/2025
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
12/24/2025
12/29/2025
PO
4ml
TID
PCAP
Checking Initial Appropriateness